Clinical Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

About the Cover

Cover Figure


The Cover

A summary of DNA copy number aberrations detected by CGH in 26 esophageal squamous cell carcinomas. Gains and losses in tumors without lymph node metastasis (n = 17) are indicated by green and pink lines. Gains and losses in tumors with lymph node metastasis (n = 9) are indicated by blue and red lines. Gains of 8q24 and/or 20q were observed in 12, including all (9/9) with nodal metastasis. Fourteen tumors had neither gain of 8q24 nor 20q. For details, see T. Ueno et al., in this issue.



[Table of Contents]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2004 by the American Association for Cancer Research.